{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:45:59Z","timestamp":1774914359992,"version":"3.50.1"},"reference-count":248,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CB-252942"],"award-info":[{"award-number":["CB-252942"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["1320"],"award-info":[{"award-number":["1320"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["280788"],"award-info":[{"award-number":["280788"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["205941"],"award-info":[{"award-number":["205941"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CB-38154"],"award-info":[{"award-number":["CB-38154"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FUNDHEPA"},{"DOI":"10.13039\/501100004173","name":"Universidad Aut\u00f3noma Metropolitana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004173","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consejo Nacional de Investigaciones Cient\u00edficas y Tecnol\u00f3gicas","award":["PUE-CONICET 0089"],"award-info":[{"award-number":["PUE-CONICET 0089"]}]},{"DOI":"10.13039\/501100003074","name":"Agencia de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"crossref","award":["PICT-2016-1613"],"award-info":[{"award-number":["PICT-2016-1613"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.lfs.2018.12.044","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T11:39:56Z","timestamp":1546429196000},"page":"324-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies"],"prefix":"10.1016","volume":"218","author":[{"given":"Soraya","family":"Salas-Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Simoni-Nieves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Bucio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis E.","family":"G\u00f3mez-Quiroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Concepci\u00f3n","family":"Guti\u00e9rrez-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-9801","authenticated-orcid":false,"given":"Marcelo G.","family":"Roma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2018.12.044_bb0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)32126-X","article-title":"Cholestasis: human disease and experimental animal models","volume":"2","author":"Rodriguez-Garay","year":"2003","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0010","doi-asserted-by":"crossref","first-page":"9895176","DOI":"10.1155\/2016\/9895176","article-title":"Liver cholesterol overload aggravates obstructive cholestasis by inducing oxidative stress and premature death in mice","volume":"2016","author":"Nuno-Lambarri","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.biocel.2009.07.020","article-title":"Biliary differentiation and bile duct morphogenesis in development and disease","volume":"43","author":"Raynaud","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0030","first-page":"1367","article-title":"How the biliary tree maintains immune tolerance?","volume":"2018","author":"Zhang","year":"1864","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2018.12.044_bb0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","article-title":"Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","volume":"158","author":"Trauner","year":"2008","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.lfs.2018.12.044_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s005340170002","article-title":"Pathology and pathogenesis of intrahepatic bile duct loss","volume":"8","author":"Nakanuma","year":"2001","journal-title":"J. Hepato-Biliary-Pancreat. Surg."},{"key":"10.1016\/j.lfs.2018.12.044_bb0045","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2014.11.027","article-title":"Autophagy and senescence in fibrosing cholangiopathies","volume":"62","author":"Nakanuma","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0050","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20070227","article-title":"Hepatocellular transport in acquired cholestasis: new insights into functional, regulatory and therapeutic aspects","volume":"114","author":"Roma","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.lfs.2018.12.044_bb0055","first-page":"427","article-title":"Transport systems in cholangiocytes: their role in bile formation and cholestasis","volume":"70","author":"Strazzabosco","year":"1997","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury - what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.anndiagpath.2015.06.002","article-title":"Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases","volume":"19","author":"Vij","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0070","first-page":"1232","article-title":"Drug and toxin-induced bile duct disorders","volume":"15","author":"Geubel","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00534-005-1080-2","article-title":"Causes and consequences of ischemic-type biliary lesions after liver transplantation","volume":"13","author":"Buis","year":"2006","journal-title":"J. Hepato-Biliary-Pancreat. Surg."},{"key":"10.1016\/j.lfs.2018.12.044_bb0080","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.bbadis.2017.06.013","article-title":"Post-transplant cholangiopathy: classification, pathogenesis, and preventive strategies","volume":"1864","author":"de V","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2018.12.044_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cld.2007.11.007","article-title":"Vanishing bile duct syndrome","volume":"12","author":"Reau","year":"2008","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bpg.2010.07.005","article-title":"Primary sclerosing cholangitis","volume":"24","author":"Karlsen","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0095","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1089-3261(02)00010-7","article-title":"Primary biliary cirrhosis and other ductopenic diseases","volume":"6","author":"Burt","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2559.1998.00399.x","article-title":"Intrahepatic bile duct loss in primary sclerosing cholangitis: a quantitative study","volume":"32","author":"Casali","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2018.12.044_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O'Mahony","year":"2006","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","article-title":"p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ","volume":"59","author":"Terjung","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2018.12.044_bb0130","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41385-018-0066-8","article-title":"Natural killer T cells mediate inflammation in the bile ducts","volume":"11","author":"Berntsen","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.12.044_bb0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0037-1603324","article-title":"Epigenetics in the primary biliary cholangitis and primary sclerosing cholangitis","volume":"37","author":"Cheung","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00795-006-0321-z","article-title":"Molecular mechanisms of cholangiopathy in primary biliary cirrhosis","volume":"39","author":"Harada","year":"2006","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000450914","article-title":"The emerging role of soluble adenylyl cyclase in primary biliary cholangitis","volume":"35","author":"Chang","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0155","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2008-1040584","article-title":"New concepts in biliary cirrhosis","volume":"7","author":"Ludwig","year":"1987","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0160","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0165","first-page":"371","article-title":"A variant of obstructive biliary cirrhosis","volume":"60","author":"MacMahon","year":"1970","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.prp.2005.06.004","article-title":"Cholangitis: a histologic classification based on patterns of injury in liver biopsies","volume":"201","author":"Li","year":"2005","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2018.12.044_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000450913","article-title":"Bile acids and deregulated cholangiocyte autophagy in primary biliary cholangitis","volume":"35","author":"Sasaki","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0180","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3748\/wjg.14.3328","article-title":"Etiopathogenesis of primary biliary cirrhosis","volume":"14","author":"Lleo","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI200110716","article-title":"Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis","volume":"108","author":"Odin","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2018.12.044_bb0190","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/1744666X.2017.1391093","article-title":"From pathogenesis to novel therapies in the treatment of primary biliary cholangitis","volume":"13","author":"Ronca","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0200","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00383-017-4173-5","article-title":"Liver transplantation for biliary atresia: a systematic review","volume":"33","author":"Kasahara","year":"2017","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.lfs.2018.12.044_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180896","article-title":"Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3","volume":"12","author":"Ye","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2018.12.044_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.06.005","article-title":"Biliary atresia: a comprehensive review","volume":"73","author":"Lakshminarayanan","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2018.12.044_bb0215","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/MEG.0b013e32832e9df0","article-title":"Morphometrical and immunohistochemical study of intrahepatic bile ducts in biliary atresia","volume":"23","author":"Yamaguti","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0220","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00383-017-4175-3","article-title":"Screening for biliary atresia","volume":"33","author":"Matsui","year":"2017","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.lfs.2018.12.044_bb0225","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0002-9440(10)62328-0","article-title":"Transdifferentiation of mature rat hepatocytes into bile duct-like cells in vitro","volume":"166","author":"Nishikawa","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0230","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1242\/jcs.01169","article-title":"Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors","volume":"117","author":"Tanimizu","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.lfs.2018.12.044_bb0235","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1053\/j.gastro.2007.08.071","article-title":"Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion","volume":"133","author":"Fiorotto","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0240","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","article-title":"Phosphatidylcholine translocase: a physiological role for the mdr2 gene","volume":"77","author":"Ruetz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2018.12.044_bb0245","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-5793(94)01135-4","article-title":"The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice","volume":"354","author":"Smith","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2018.12.044_bb0250","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)","volume":"453","author":"Oude Elferink","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.lfs.2018.12.044_bb0255","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1023\/B:DDAS.0000007869.67105.27","article-title":"Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes","volume":"48","author":"Komichi","year":"2003","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2018.12.044_bb0260","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0265","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/hep.22485","article-title":"A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults","volume":"48","author":"Gotthardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13244-013-0243-y","article-title":"Hepatobiliary anomalies associated with ABCB4\/MDR3 deficiency in adults: a pictorial essay","volume":"4","author":"Benzimra","year":"2013","journal-title":"Insights Imag."},{"key":"10.1016\/j.lfs.2018.12.044_bb0275","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1665-2681(19)30771-9","article-title":"Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3","volume":"14","author":"Frider","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12889","article-title":"Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency","volume":"21","author":"Vij","year":"2017","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.lfs.2018.12.044_bb0285","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bpg.2010.08.003","article-title":"Cystic fibrosis-associated liver disease","volume":"24","author":"Herrmann","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0290","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/archdischild-2013-304159","article-title":"Cholestasis and meconium ileus in infants with cystic fibrosis and their clinical outcomes","volume":"99","author":"Leeuwen","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.lfs.2018.12.044_bb0295","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2036.2012.05177.x","article-title":"Ursodeoxycholic acid therapy in cystic fibrosis liver disease--a retrospective long-term follow-up case-control study","volume":"36","author":"Kappler","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.12.044_bb0300","first-page":"136","article-title":"Liver disease in cystic fibrosis","volume":"9","author":"Kobelska-Dubiel","year":"2014","journal-title":"Przegl. Gastroen."},{"key":"10.1016\/j.lfs.2018.12.044_bb0305","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.24183","article-title":"Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease","volume":"53","author":"Witters","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000324687","article-title":"Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man","volume":"29","author":"Hohenester","year":"2011","journal-title":"Dig. Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/JCD.S2785","article-title":"Mechanisms of biliary damage","volume":"3","author":"Yang","year":"2010","journal-title":"J. Cell Death"},{"key":"10.1016\/j.lfs.2018.12.044_bb0320","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0325","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.28016","article-title":"Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease","volume":"62","author":"Leung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0330","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0335","doi-asserted-by":"crossref","first-page":"G182","DOI":"10.1152\/ajpgi.2001.281.1.G182","article-title":"Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis","volume":"281","author":"Lesage","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0340","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1872-034X.2007.00049.x","article-title":"Amniotic epithelial cell-derived cholangiocytes in experimental cholestatic ductal hyperplasia","volume":"37","author":"Moritoki","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0345","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-483X(01)00459-0","article-title":"Role of MRP2 and GSH in intrahepatic cycling of toxins","volume":"167","author":"Dietrich","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0350","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/toxsci\/kfp020","article-title":"ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling","volume":"108","author":"Tanaka","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.lfs.2018.12.044_bb0355","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.510290242","article-title":"Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver","volume":"29","author":"LeSage","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0360","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-9556(25)07121-1","article-title":"The detection of halocarbon-derived radical adducts in bile and liver of rats","volume":"19","author":"Knecht","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2018.12.044_bb0365","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0168-8278(05)80476-3","article-title":"Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis","volume":"20","author":"Davies","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0370","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/tx0002435","article-title":"Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes","volume":"14","author":"Lakehal","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0375","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/ACI.0000000000000070","article-title":"Mechanisms of drug-induced liver injury","volume":"14","author":"Stephens","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0380","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0029-1240007","article-title":"Immunoallergic drug-induced liver injury in humans","volume":"29","author":"Uetrecht","year":"2009","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0385","doi-asserted-by":"crossref","first-page":"839682","DOI":"10.1155\/2011\/839682","article-title":"Haptenation: chemical reactivity and protein binding","volume":"2011","author":"Chipinda","year":"2011","journal-title":"J. Allergy"},{"key":"10.1016\/j.lfs.2018.12.044_bb0390","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immune-mediated drug-induced liver disease","volume":"6","author":"Liu","year":"2002","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0395","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0400","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.24508","article-title":"Cross-presentation of antigen by diverse subsets of murine liver cells","volume":"54","author":"Ebrahimkhani","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0405","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0410","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0415","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","article-title":"Liver antigen-presenting cells","volume":"54","author":"Crispe","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0420","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep.23320","article-title":"Natural killer group 2 member D, its ligands, and liver disease: good or bad?","volume":"51","author":"Gao","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0425","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.2741\/A923","article-title":"The role of cholangiocytes in the development of chronic inflammatory liver disease","volume":"7","author":"Adams","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.lfs.2018.12.044_bb0430","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.4049\/jimmunol.174.2.1055","article-title":"CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver","volume":"174","author":"Heydtmann","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0435","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH725>3.0.CO;2-P","article-title":"Monocyte chemotactic protein-1, \u22122, and \u22123 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis","volume":"193","author":"Tsuneyama","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0440","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41419-018-1014-y","article-title":"MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis","volume":"9","author":"Fernandez-Ramos","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0445","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0450","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-associated molecular patterns in inflammatory diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"10.1016\/j.lfs.2018.12.044_bb0455","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ncprheum0531","article-title":"Mechanisms of disease: a 'DAMP' view of inflammatory arthritis","volume":"3","author":"Foell","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0460","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.4049\/jimmunol.175.11.7447","article-title":"Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB","volume":"175","author":"Chen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0465","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hep.21522","article-title":"AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers","volume":"45","author":"Moritoki","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0470","first-page":"105","article-title":"Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy","volume":"14","author":"Waldmann","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2018.12.044_bb0475","series-title":"Liver Immunology - Principles and Practice","first-page":"363","article-title":"Immune mechanisms in drug-induced hepatotoxicity","author":"Liu","year":"2007"},{"key":"10.1016\/j.lfs.2018.12.044_bb0480","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpg.2011.02.001","article-title":"Fibrosis in autoimmune and cholestatic liver disease","volume":"25","author":"Penz-Osterreicher","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0485","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/hep.510300614","article-title":"The canals of Hering and hepatic stem cells in humans","volume":"30","author":"Theise","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0490","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.510260604","article-title":"Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis","volume":"26","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0495","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1038\/sj.onc.1209608","article-title":"Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy","volume":"25","author":"Fulda","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2018.12.044_bb0500","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4161\/cbt.4.2.1508","article-title":"Overview of cell death signaling pathways","volume":"4","author":"Jin","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.lfs.2018.12.044_bb0505","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/jhep.2002.33541","article-title":"The pathobiology of biliary epithelia","volume":"35","author":"Alpini","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0510","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0032-1329899","article-title":"Clues to the etiology of bile duct injury in biliary atresia","volume":"32","author":"Mack","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0515","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.0106-9543.2002.01595.x","article-title":"Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"22","author":"Tinmouth","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.lfs.2018.12.044_bb0520","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/hepr.12304","article-title":"Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases","volume":"44","author":"Denk","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0525","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1007\/s10620-015-3805-7","article-title":"Individuals with primary sclerosing cholangitis have elevated levels of biomarkers for apoptosis but not necrosis","volume":"60","author":"Masuoka","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2018.12.044_bb0530","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1440-1711.1999.00837.x","article-title":"Cell death induced by the Fas\/Fas ligand pathway and its role in pathology","volume":"77","author":"Waring","year":"1999","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0535","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/370558a0","article-title":"Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor","volume":"370","author":"McGeehan","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2018.12.044_bb0540","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.187.8.1205","article-title":"Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity","volume":"187","author":"Schneider","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0545","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0550","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X","article-title":"Surface expression of TRAIL\/Apo-2 ligand in activated mouse T and B cells","volume":"28","author":"Mariani","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0555","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0560","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1111\/ajt.12271","article-title":"Biliary epithelial senescence and plasticity in acute cellular rejection","volume":"13","author":"Brain","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2018.12.044_bb0565","first-page":"119","article-title":"Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis","volume":"429","author":"Kuroki","year":"1996","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lfs.2018.12.044_bb0570","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jhep.2004.11.023","article-title":"Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis","volume":"42","author":"Tsikrikoni","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-0676.2000.020002129.x","article-title":"Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis","volume":"20","author":"Iwata","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.lfs.2018.12.044_bb0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s004280050077","article-title":"Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"431","author":"Dienes","year":"1997","journal-title":"Virchows Arch."},{"key":"10.1016\/j.lfs.2018.12.044_bb0585","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0168-8278(97)80418-7","article-title":"The apoptosis protector, bcl-2 protein, is downregulated in bile duct epithelial cells of human liver allografts","volume":"26","author":"Gapany","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0590","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-2007-1007153","article-title":"Dysregulation of apoptosis in the cholangiopathies and cholangiocarcinoma","volume":"18","author":"Celli","year":"1998","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10238-008-0149-z","article-title":"Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis","volume":"8","author":"Liang","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0605","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCG.0b013e3181662426","article-title":"A double-blind, placebo-controlled, randomized study of infliximab in primary sclerosing cholangitis","volume":"42","author":"Hommes","year":"2008","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0610","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trsl.2006.04.007","article-title":"Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray","volume":"148","author":"Baba","year":"2006","journal-title":"Transl. Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0615","doi-asserted-by":"crossref","first-page":"38610","DOI":"10.1074\/jbc.M105300200","article-title":"The bile acid glycochenodeoxycholate induces trail-receptor 2\/DR5 expression and apoptosis","volume":"276","author":"Higuchi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.044_bb0620","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1074\/jbc.M309476200","article-title":"Bile acids up-regulate death receptor 5\/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1","volume":"279","author":"Higuchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.044_bb0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2249.2006.03293.x","article-title":"Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C","volume":"148","author":"Pelli","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0630","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.459","article-title":"Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice","volume":"8","author":"Guicciardi","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0635","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.1073\/pnas.0802702105","article-title":"Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease","volume":"105","author":"Takeda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2018.12.044_bb0640","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH793>3.0.CO;2-O","article-title":"CD8+ T cells infiltrating into bile ducts in biliary atresia do not appear to function as cytotoxic T cells: a clinicopathological analysis","volume":"193","author":"Ahmed","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0645","first-page":"521","article-title":"Molecular biology of Bax and Bak activation and action","volume":"2011","author":"Westphal","year":"1813","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2018.12.044_bb0650","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/febs.13527","article-title":"Discoveries and controversies in BCL-2 protein-mediated apoptosis","volume":"283","author":"Zheng","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2018.12.044_bb0655","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0660","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042737-199807000-00005","article-title":"Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis","volume":"10","author":"Graham","year":"1998","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0665","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0046-8177(00)80217-8","article-title":"Expression of Bcl-2 familial proteins is reduced in small bile duct lesions of primary biliary cirrhosis","volume":"31","author":"Iwata","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0670","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2559.2000.00982.x","article-title":"Distribution of apoptotic cells and expression of apoptosis-related proteins along the intrahepatic biliary tree in normal and non-biliary diseased liver","volume":"37","author":"Harada","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0675","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0680","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0676.2001.021004272.x","article-title":"Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis","volume":"21","author":"Fox","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.lfs.2018.12.044_bb0685","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0690","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/jhep.2002.30280","article-title":"Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases","volume":"35","author":"Matsumura","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0695","first-page":"1725","article-title":"Apoptosis and hepatobiliary disease","volume":"21","author":"Patel","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0700","first-page":"1835","article-title":"Intracellular ATP levels determine cell death fate by apoptosis or necrosis","volume":"57","author":"Eguchi","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0705","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00535-010-0249-x","article-title":"Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis","volume":"45","author":"Sorrentino","year":"2010","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0710","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0168-8278(01)00171-4","article-title":"In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease","volume":"35","author":"Kitada","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0715","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1872-034X.2007.00093.x","article-title":"Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and primary biliary cirrhosis: in situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi","volume":"37","author":"Kadokawa","year":"2007","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0720","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0168-8278(00)00075-1","article-title":"Increased expression of WAF1 in intrahepatic bile ducts in primary biliary cirrhosis relates to apoptosis","volume":"34","author":"Harada","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0725","first-page":"313","article-title":"Primary sclerosing cholangitis","volume":"44","author":"Cecere","year":"2002","journal-title":"Panminerva Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0730","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1742-4658.2005.05103.x","article-title":"Calcium, mitochondria and oxidative stress in neuronal pathology. Novel aspects of an enduring theme","volume":"273","author":"Chinopoulos","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2018.12.044_bb0735","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0740","doi-asserted-by":"crossref","first-page":"3527579","DOI":"10.1155\/2016\/3527579","article-title":"Xanthine oxidoreductase-derived reactive species: physiological and pathological effects","volume":"2016","author":"Battelli","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0745","first-page":"164329","article-title":"Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation","volume":"2012","author":"Cursio","year":"2012","journal-title":"J. Transp. Secur."},{"key":"10.1016\/j.lfs.2018.12.044_bb0750","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2007.04.002","article-title":"Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis","volume":"29","author":"Salunga","year":"2007","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2018.12.044_bb0755","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0168-8278(90)90143-F","article-title":"Biochemical studies on bile duct epithelial cells isolated from rat liver","volume":"10","author":"Parola","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0760","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cld.2009.07.004","article-title":"Endoplasmic reticulum stress and the unfolded protein response","volume":"13","author":"Kapoor","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0765","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2478\/s11658-006-0040-4","article-title":"Endoplasmic reticulum stress and apoptosis","volume":"11","author":"Faitova","year":"2006","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2018.12.044_bb0770","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.cdd.4401364","article-title":"Caspase-12: an overview","volume":"11","author":"Lamkanfi","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2018.12.044_bb0775","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2010.11.005","article-title":"Endoplasmic reticulum stress in liver disease","volume":"54","author":"Malhi","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0780","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0785","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0790","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.044_bb0795","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2007.08.020","article-title":"Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile","volume":"133","author":"Minagawa","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0800","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/187152810791292809","article-title":"Biliary innate immunity in the pathogenesis of biliary diseases","volume":"9","author":"Harada","year":"2010","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.lfs.2018.12.044_bb0805","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2018.12.044_bb0815","doi-asserted-by":"crossref","first-page":"452143","DOI":"10.1155\/2012\/452143","article-title":"Novel approach to bile duct damage in primary biliary cirrhosis: participation of cellular senescence and autophagy","volume":"2012","author":"Sasaki","year":"2012","journal-title":"Int. J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0820","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.28831","article-title":"Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in micedouble dagger","volume":"65","author":"McDaniel","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0825","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2741\/e539","article-title":"Mitochondrial dysfunction in cholestatic liver diseases","volume":"4","author":"Arduini","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.lfs.2018.12.044_bb0830","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.201009094","article-title":"Four faces of cellular senescence","volume":"192","author":"Rodier","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0835","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"Meng","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0840","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/152308602760598918","article-title":"Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy","volume":"4","author":"Lemasters","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2018.12.044_bb0845","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0006-291X(03)00618-1","article-title":"Mitochondrial permeability transition: a common pathway to necrosis and apoptosis","volume":"304","author":"Kim","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.12.044_bb0850","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2007-991516","article-title":"Cholangiocyte injury and ductopenic syndromes","volume":"27","author":"Xia","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0855","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0860","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jhep.2006.01.009","article-title":"Ischemic cholangiopathy","volume":"44","author":"Deltenre","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0865","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nrm.2016.149","article-title":"Necroptosis in development, inflammation and disease","volume":"18","author":"Weinlich","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0870","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clinre.2016.08.002","article-title":"Stress-induced cellular responses and cell death mechanisms during inflammatory cholangiopathies","volume":"41","author":"Sasaki","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0875","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.280","article-title":"Activation of necroptosis in human and experimental cholestasis","volume":"7","author":"Afonso","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb0880","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","article-title":"Necroptosis in health and diseases","volume":"35","author":"Zhou","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0885","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/imr.12541","article-title":"Caspase-8: regulating life and death","volume":"277","author":"Tummers","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0890","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1101\/gad.223321.113","article-title":"RIP3: a molecular switch for necrosis and inflammation","volume":"27","author":"Moriwaki","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.lfs.2018.12.044_bb0895","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/labinvest.2016.112","article-title":"Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice","volume":"96","author":"Kennedy","year":"2016","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2018.12.044_bb0900","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1111\/ajt.12447","article-title":"RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival","volume":"13","author":"Lau","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.lfs.2018.12.044_bb0905","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20110184","article-title":"Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications","volume":"121","author":"Roma","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.lfs.2018.12.044_bb0910","first-page":"1484","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian group for the study of ursodeoxycholic acid in cystic fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0915","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcf.2011.08.002","article-title":"Ursodeoxycholic acid in cystic fibrosis-associated liver disease","volume":"11","author":"Ooi","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.lfs.2018.12.044_bb0920","doi-asserted-by":"crossref","first-page":"e1236","DOI":"10.1542\/peds.2008-0986","article-title":"Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia","volume":"122","author":"Willot","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.lfs.2018.12.044_bb0925","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5604\/16652681.1198824","article-title":"Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction","volume":"15","author":"Bessone","year":"2016","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365529409103618","article-title":"Pharmacology of ursodeoxycholic acid, an enterohepatic drug","volume":"204","author":"Hofmann","year":"1994","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.lfs.2018.12.044_bb0935","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1194\/jlr.R900011-JLR200","article-title":"Bile acids: regulation of apoptosis by ursodeoxycholic acid","volume":"50","author":"Amaral","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.lfs.2018.12.044_bb0940","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.cbi.2010.08.004","article-title":"Tauroursodeoxycholate counteracts hepatocellular lysis induced by tensioactive bile salts by preventing plasma membrane-micelle transition","volume":"188","author":"Basiglio","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2018.12.044_bb0945","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-3565(25)24517-7","article-title":"Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection","volume":"272","author":"Botla","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2018.12.044_bb0950","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03401914","article-title":"Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production","volume":"4","author":"Rodrigues","year":"1998","journal-title":"Mol. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb0955","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1053\/jhep.2001.28510","article-title":"Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione","volume":"34","author":"Colell","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0960","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2002.34511","article-title":"Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes","volume":"36","author":"Azzaroli","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0965","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2018.12.044_bb0970","doi-asserted-by":"crossref","first-page":"34250","DOI":"10.1074\/jbc.M704075200","article-title":"p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis","volume":"282","author":"Amaral","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2018.12.044_bb0975","first-page":"1303","article-title":"Signaling pathways mediated by tumor necrosis factor alpha","volume":"15","author":"Leong","year":"2000","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb0980","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/jhep.2002.35441","article-title":"Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation","volume":"36","author":"Xie","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0985","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.1128294","article-title":"Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes","volume":"313","author":"Ozcan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.lfs.2018.12.044_bb0990","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.20246","article-title":"Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways","volume":"39","author":"Schoemaker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb0995","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1207\/s15327914nc5101_15","article-title":"Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt\/PKB-dependent survival signaling","volume":"51","author":"Im","year":"2005","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2018.12.044_bb1000","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2353\/ajpath.2006.050126","article-title":"Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts","volume":"168","author":"Marzioni","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1005","doi-asserted-by":"crossref","first-page":"G923","DOI":"10.1152\/ajpgi.00490.2005","article-title":"Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha\/beta in the adaptive response to bile acids","volume":"290","author":"Zollner","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1010","doi-asserted-by":"crossref","first-page":"39411","DOI":"10.1074\/jbc.M106340200","article-title":"Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450","volume":"276","author":"Schuetz","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2018.12.044_bb1015","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","article-title":"Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action","volume":"36","author":"Poupon","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1025","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor alpha activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1035","first-page":"695","article-title":"Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells","volume":"118","author":"Arenas","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2018.12.044_bb1040","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20943","article-title":"Novel biotransformation and physiological properties of norursodeoxycholic acid in humans","volume":"42","author":"Hofmann","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1055","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/0006-291X(92)91146-H","article-title":"Ursodeoxycholic acid-dependent activation of the glucocorticoid receptor","volume":"188","author":"Tanaka","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2018.12.044_bb1060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1065","first-page":"596","article-title":"Ursodeoxycholic acid (UDCA) suppresses liver interleukin 2 mRNA in the cholangitis model","volume":"52","author":"Miyaguchi","year":"2005","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1070","first-page":"1194","article-title":"Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy","volume":"86","author":"Terasaki","year":"1991","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1075","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2169\/internalmedicine.42.1259","article-title":"Ursodeoxycholic acid therapy attenuated expression of adhesion molecule in primary biliary cirrhosis","volume":"42","author":"Yokomori","year":"2003","journal-title":"Intern. Med."},{"key":"10.1016\/j.lfs.2018.12.044_bb1080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-017-0345-y","article-title":"Why doesn't primary biliary cholangitis respond to immunosuppressive medications?","volume":"16","author":"Molinaro","year":"2017","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.lfs.2018.12.044_bb1090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000471874","article-title":"Immunosuppressive agents for the treatment of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"35","author":"Peng","year":"2017","journal-title":"Dig. Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb1095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/apt.12581","article-title":"Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Karlsen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2018.12.044_bb1100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.1840100405","article-title":"A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss","volume":"10","author":"Mitchison","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1742-7843.2009.00474.x","article-title":"Vanishing bile duct syndrome associated with azithromycin in a 62-year-old man","volume":"106","author":"Juricic","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1110","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1023\/A:1012351231143","article-title":"Stevens-Johnson syndrome and cholestatic hepatitis","volume":"46","author":"Morelli","year":"2001","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.lfs.2018.12.044_bb1115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1440-1754.2008.01291.x","article-title":"A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder","volume":"44","author":"Tajiri","year":"2008","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.lfs.2018.12.044_bb1120","doi-asserted-by":"crossref","first-page":"e1194","DOI":"10.1542\/peds.2013-2239","article-title":"Infliximab\/plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis","volume":"134","author":"White","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.lfs.2018.12.044_bb1125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S1665-2681(19)32029-0","article-title":"Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms","volume":"5","author":"Karnsakul","year":"2006","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1130","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3349\/ymj.2014.55.3.834","article-title":"Ibuprofen associated acute vanishing bile duct syndrome and toxic epidermal necrolysis in an infant","volume":"55","author":"Kim","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.lfs.2018.12.044_bb1135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1442-200X.2006.02268.x","article-title":"Vanishing bile duct syndrome with a history of erythema multiforme","volume":"48","author":"Takeyama","year":"2006","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.lfs.2018.12.044_bb1140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4253\/wjge.v4.i8.376","article-title":"Drug associated vanishing bile duct syndrome combined with hemophagocytic lymphohistiocytosis","volume":"4","author":"Li","year":"2012","journal-title":"World J. Gastrointest. Endosc."},{"key":"10.1016\/j.lfs.2018.12.044_bb1145","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.3748\/wjg.v13.i45.6087","article-title":"Mycophenolate mofetil for drug-induced vanishing bile duct syndrome","volume":"13","author":"Jakab","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1150","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.3748\/wjg.14.4697","article-title":"Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus","volume":"14","author":"Okan","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1155","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/hep.20130","article-title":"Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers","volume":"39","author":"Roskams","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1160","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.24613","article-title":"Ductular reactions in human liver: diversity at the interface","volume":"54","author":"Gouw","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.28326","article-title":"The hepatic, biliary, and pancreatic network of stem\/progenitor cell niches in humans: a new reference frame for disease and regeneration","volume":"64","author":"Lanzoni","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1170","first-page":"1524","article-title":"Repopulating the biliary tree from the peribiliary glands","volume":"2018","author":"de Jong","year":"1864","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2018.12.044_bb1175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3727\/105221616X692568","article-title":"Regulators of cholangiocyte proliferation","volume":"17","author":"Hall","year":"2017","journal-title":"Gene Expr."},{"key":"10.1016\/j.lfs.2018.12.044_bb1180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.gastro.2007.04.007","article-title":"Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis","volume":"133","author":"Marzioni","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1185","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.23657","article-title":"Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation","volume":"52","author":"Glaser","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1190","first-page":"G767","article-title":"Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation","volume":"274","author":"Alpini","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2018.12.044_bb1195","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/labinvest.2009.6","article-title":"Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium","volume":"89","author":"Glaser","year":"2009","journal-title":"Lab. Investig."},{"key":"10.1016\/j.lfs.2018.12.044_bb1200","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1152\/ajpcell.00369.2007","article-title":"Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3\/CaMK I\/CREB pathway","volume":"295","author":"Francis","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1205","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2353\/ajpath.2010.090677","article-title":"After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes","volume":"176","author":"Mancinelli","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1210","first-page":"G1289","article-title":"Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver","volume":"276","author":"LeSage","year":"1999","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.lfs.2018.12.044_bb1215","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ajpath.2010.09.043","article-title":"Regulation of biliary proliferation by neuroendocrine factors: implications for the pathogenesis of cholestatic liver diseases","volume":"178","author":"Munshi","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2018.12.044_bb1220","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.gastro.2006.07.023","article-title":"Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver","volume":"132","author":"Alvaro","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1225","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00007890-199105000-00014","article-title":"Vanishing bile-duct syndrome following liver transplantation\u2013is it reversible?","volume":"51","author":"Hubscher","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.lfs.2018.12.044_bb1230","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2011.04.030","article-title":"Polycystic liver diseases: congenital disorders of cholangiocyte signaling","volume":"140","author":"Strazzabosco","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1235","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.22623","article-title":"Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton basic research single-topic conference","volume":"48","author":"Sirica","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2018.12.044_bb1240","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2008.165688","article-title":"GLP-1 analogues: a new therapeutic approach to prevent ductopenia in cholangiopathies?","volume":"58","author":"Beuers","year":"2009","journal-title":"Gut"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320518308373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:22:48Z","timestamp":1758399768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320518308373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":248,"alternative-id":["S0024320518308373"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.044","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholangiocyte death in ductopenic cholestatic cholangiopathies: Mechanistic basis and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2018.12.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}